| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.09 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |